To be clear, the DEA rescheduled Epidiolex, not cannabidiol (CBD). The Controlled Substances Act (CSA) does not list- nor has it ever listed- CBD on any of its schedules. CBD is only unlawful when it is derived from marijuana. Epidiolex contains CBD derived from marijuana, thus requiring rescheduling in order to be prescribed. However, CBD derived from a lawful source is lawful and is not scheduled.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.